Pamiparib in patients with locally advanced or metastatic HER2-negative breast cancer with germline BRCA mutations: a phase II study.

Binghe XuTao SunYanxia ShiJiuwei CuiYongmei YinQuchang OuyangQiang LiuQingyuan ZhangYiding ChenShouman WangXiaojia WangZhongsheng TongYahua ZhongJiayu WangMin YanXi YanChuan WangJifeng FengXiuli WangGang HuYing ChengRuimin GeZhaoyin ZhuWa ZhangZhimin Shao

Published in: Breast cancer research and treatment (2022)

ClinicalTrials.gov, NCT03575065; July 2, 2018.

Keyphrases

phase ii study
locally advanced
squamous cell carcinoma
rectal cancer
neoadjuvant chemotherapy
breast cancer risk
radiation therapy
small cell lung cancer
dna repair
open label
clinical trial
dna damage